Hansen Medical(R) to Highlight Benefits and Future of Magellan(TM) Robotic System Technology and Present Magellan Robotic System at Charing Cross International Symposium

MOUNTAIN VIEW, CA--(Marketwired - Apr 25, 2016) - Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan™ Robotic System at the Charing Cross International Symposium in London, United Kingdom from April 26^th to April 29^th.

At the 38^th annual symposium, the Magellan Robotic System and family of Magellan Robotic Catheters will be showcased and available for demonstrations at exhibit booth #215. Hansen Medical also anticipates that intravascular robotics will be discussed during the following sessions at Charing Cross:

• April 26, 14:40, Robotic-assisted endovascular aneurysm repairs: improved efficiency compared to manual techniques for contralateral gate cannulation- Celia Riga, MD (London, UK)
• April 27, 10:40, Case experience of iliac artery treatment with robotic hybrid approach- Fabien Thaveau, MD (Strasbourg, France)
• April 27, 12:10, The Magellan Robotic Catheter eKit and potential for radiation dose reduction- Celia Riga, MD (London, UK)
• April 28, 08:14, Improving procedural success in complex pathologies with robotics and advanced imaging - Barry Katzen, MD (Miami, US)
• April 28, 08:30, Successful use of robotics in failed treatment of central venous stenosis - Alan Lumsden, MD (Houston, US)
• April 28, 08:37, Inferior vena cava filter retrieval with robotics - Alan Lumsden, MD (Houston, US)
• April 28, 09:37, Robotic benefits for endovascular procedures - Celia Riga, MD (London, UK)
• April 28, 14:33, Methods to reduce radiation exposure during endovascular procedures - Barry Katzen, MD (Miami, US)
• April 28, 15:45, The role of robotics in advanced endovascular procedures, Celia Riga, MD, (London, UK)

Additionally, Hansen Medical will host two physician presentations at its booth as a part of CX Imaging Day. These will focus on new clinical data and experiences with the current system and insights from Dr. Lumsden about his research with future robotic technology. The presentations include:

• April 28, 12:30, Clinical Experiences with Intravascular Robotics, Barry Katzen, MD (Miami, US) (Hansen Booth 215)
• April 28, 15:45, Flexible Robotics with Electromagnetic Tracking and the Impacts of Safety & Efficiency, Alan Lumsden, MD (Houston, US) (Hansen Booth 215)

"We are looking forward to having a strong presence at Charing Cross this year and are eager to connect with the vascular and endovascular community," said Cary Vance, Hansen Medical's President and Chief Executive Officer. "Our present Magellan users have gained great insights in clinical and research applications both with current and future technology, and we positively anticipate the new data and case reports that they will highlight during the symposium."